Anti-snoring Treatment Market
Anti- Snoring Treatment Market Size, Share & Trends Analysis Report by Product Type (Mandibular Advancement Devices (MADs), Nasal Devices, Positive Airway Pressure (PAP) Devices, Chin Straps, Position Control Devices, and Tongue Stabilizing Devices (TSDs)), by Treatment Type (Device-based Treatment, Surgical Treatment, Pharmacological Treatment, and Lifestyle & Behavioral Therapy), by End User (Hospitals, Sleep Clinics & Diagnostic Centers, Homecare Settings, and ENT Clinics), Forecast Period (2026–2035)
Industry Overview
Anti - snoring treatment market was valued at $1.9 billion in 2025 and is projected to reach $3.8 billion by 2035, growing at a CAGR of 7.3% during the forecast period (2026-2035). The market is expanding due to the rising prevalence of sleep-related breathing disorders and increasing clinical recognition of snoring as a health concern. Growing adoption of non-invasive therapeutic solutions, particularly oral appliances and PAP systems, is supporting sustained demand. Technological refinement in device comfort, portability, and patient compliance has improved treatment adherence rates. Increased availability of over-the-counter solutions and digital health integration is further widening access. In addition, a shift toward home-based care settings is contributing to consistent market progression.
Market Dynamics
Rising Clinical Burden and Diagnosis Rates
A steady increase in the diagnosed population suffering from sleep-disordered breathing conditions is reinforcing demand for anti-snoring interventions. Clinical awareness has improved significantly, supported by screening initiatives and integration of sleep studies in routine diagnostics. Urban lifestyles, obesity prevalence, and aging demographics continue to influence patient volumes requiring therapeutic management. Healthcare providers are increasingly recommending early-stage interventions such as mandibular devices and nasal dilators to prevent disease progression. In parallel, the availability of specialized sleep clinics and diagnostic centers is enhancing case identification rates. Reimbursement support in developed healthcare systems is also facilitating treatment uptake. Moreover, increased physician preference for non-surgical approaches is strengthening device adoption across mild to moderate cases.
Technological Advancements and Shift toward Patient-Centric Devices
Continuous innovation in device design and functionality is a key growth enabler across this market. Manufacturers are focusing on ergonomic improvements, customization capabilities, and integration of smart monitoring features to enhance patient compliance. The development of digitally connected PAP systems and wearable positional therapy devices is reshaping treatment pathways. Companies are also introducing minimally intrusive oral appliances that improve comfort during prolonged usage. Expansion of direct-to-consumer channels is supporting faster product penetration, particularly in homecare settings. In addition, regulatory approvals for newer neuromuscular stimulation devices are expanding the treatment landscape. These advancements are aligning with patient preferences for convenience and non-invasive care solutions, thereby accelerating adoption rates.
Market Segmentation
- Based on the product type, the market is segmented into mandibular advancement devices (MADs), nasal devices, positive airway pressure (PAP) devices, chin straps, position control devices, and tongue stabilizing devices (TSDs).
- Based on the treatment type, the market is segmented into device-based treatment, surgical treatment, pharmacological treatment, and lifestyle and behavioral therapy.
- Based on the end user, the market is segmented into hospitals, sleep clinics and diagnostic centers, homecare settings, and ENT clinics.
Dominance of Mandibular Advancement Devices (MADs)
Mandibular advancement devices represent a leading product segment due to their clinical effectiveness in managing mild to moderate snoring conditions. These devices are widely prescribed by dental and sleep specialists owing to their ease of use and high patient compliance. Companies such as ResMed Inc., SomnoMed Limited, and ProSomnus Sleep Technologies, Inc. have expanded their product portfolios with customizable and digitally designed oral appliances. Increased preference for non-invasive alternatives over surgical interventions is further strengthening this segment. Advancements in material design and precision fitting technologies are enhancing treatment outcomes. Growing availability through both clinical and retail channels is also supporting broader adoption.
Accelerated Growth in Homecare Settings
Homecare settings are emerging as the fastest-growing end-user segment, driven by increasing patient preference for self-managed treatment solutions. The expansion of e-commerce platforms and direct-to-consumer sales models has significantly improved product accessibility. Devices such as nasal dilators, chin straps, and portable PAP systems are gaining traction among users seeking convenience. Key players including Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, and Rhinomed Limited are focusing on user-friendly and compact product designs. The growing emphasis on remote monitoring and telehealth integration is further enabling at-home therapy management. Cost advantages and reduced dependency on clinical visits are reinforcing the segment’s rapid growth trajectory.
Regional Outlook
The global anti snoring treatment market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
North America: Established Clinical Ecosystem Driving Adoption
North America continues to hold a significant position due to a well-established healthcare infrastructure and high awareness regarding sleep disorders. The region benefits from a strong presence of leading manufacturers such as ResMed Inc. and Koninklijke Philips N.V., along with advanced diagnostic facilities. Higher diagnosis rates and favorable reimbursement frameworks are supporting consistent product demand. Adoption of technologically advanced PAP devices and oral appliances remains strong across the United States and Canada. In addition, increasing investments in sleep research and digital health solutions are contributing to market expansion. Consumer inclination toward home-based therapies is also reinforcing regional growth.
Asia-Pacific: Expanding Patient Base and Improving Access
Asia-Pacific is witnessing notable growth, supported by a large untreated population and improving healthcare accessibility. Rapid urbanization and lifestyle changes are contributing to a higher incidence of sleep-related disorders across countries such as China, India, and Japan. Market participants including Oventus Medical Limited, Fisher & Paykel Healthcare Limited, and local manufacturers are expanding their regional footprint. Increasing awareness campaigns and the development of sleep clinics are enhancing diagnosis and treatment rates. Cost-effective product offerings and rising penetration of online sales channels are further supporting adoption. Government initiatives aimed at strengthening healthcare infrastructure are also playing a role in market development.
Market Players Outlook
The major companies operating in the global anti snoring treatment market include ResMed Inc., Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, SomnoMed Limited, ProSomnus Sleep Technologies, Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In February 2026, Resmed opened a new distribution center in Greenwood, Indiana. Scheduled to begin operations in 2027, the center will expand Resmed’s US presence and strengthen the company's distribution capacity to better serve patients and providers across North America.
- In September 2025, ResMed Inc. launched the Sleep Institute initiative, aimed at advancing clinical research, improving diagnostic pathways, and supporting innovation in sleep health management through global collaboration.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global anti snoring treatment Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Global Anti-snoring Treatment Market Sales Analysis – Product Type | Treatment Type | End User | Region ($ Million)
• Anti-snoring Treatment Market Sales Performance of Top Countries
1.1 Research Methodology
• Primary Research Approach
• Secondary Research Approach
1.2 Market Snapshot
- Market Overview and Insights
2.1 Scope of the Study
2.2 Analyst Insight & Current Market Trends
??2.2.1 Key Anti-snoring Treatment Market Trends
??2.2.2 Market Recommendations
2.3 Porter's Five Forces Analysis for the Anti-snoring Treatment Market
??2.3.1 Competitive Rivalry
??2.3.2 Threat of New Entrants
??2.3.3 Bargaining Power of Suppliers
??2.3.4 Bargaining Power of Buyers
??2.3.5 Threat of Substitutes
- Market Determinants
3.1 Market Drivers
??3.1.1 Drivers For Global Anti-snoring Treatment Market: Impact Analysis
3.2 Market Pain Points and Challenges
??3.2.1 Restraints For Global Anti-snoring Treatment Market: Impact Analysis
3.3 Market Opportunities
??3.3.1 Opportunities For Global Anti-snoring Treatment Market: Impact Analysis
- Competitive Landscape
4.1 Competitive Dashboard – Anti-snoring Treatment Market Revenue and Share by Manufacturers
• Anti-snoring Treatment Product Comparison Analysis
• Top Market Player Ranking Matrix
4.2 Key Company Analysis
??4.2.1 ResMed Inc.
????4.2.1.1 Overview
????4.2.1.2 Product Portfolio
????4.2.1.3 Financial Analysis
????4.2.1.4 SWOT Analysis
????4.2.1.5 Business Strategy
??4.2.2 Koninklijke Philips N.V.
??4.2.3 Fisher & Paykel Healthcare Limited
??4.2.4 SomnoMed Limited
??4.2.5 ProSomnus Sleep Technologies, Inc.
4.3 Top Winning Strategies by Market Players
??4.3.1 Merger and Acquisition
??4.3.2 Product Launch
??4.3.3 Partnership And Collaboration
- Global Anti-snoring Treatment Market Sales Analysis by Product Type ($ Million)
5.1 Mandibular Advancement Devices (MADs)
5.2 Nasal Devices
5.3 Positive Airway Pressure (PAP) Devices
5.4 Chin Straps
5.5 Position Control Devices
5.6 Tongue Stabilizing Devices (TSDs)
- Global Anti-snoring Treatment Market Sales Analysis by Treatment Type ($ Million)
6.1 Device-based Treatment
6.2 Surgical Treatment
6.3 Pharmacological Treatment
6.4 Lifestyle & Behavioral Therapy
- Global Anti-snoring Treatment Market Sales Analysis by End User ($ Million)
7.1 Hospitals
7.2 Sleep Clinics & Diagnostic Centers
7.3 Homecare Settings
7.4 ENT Clinics
- Regional Analysis
???8.1 North American Anti-snoring Treatment Market Sales Analysis – Product Type | Treatment Type | End User | Country ($ Million)
?????8.1.1 United States
?????8.1.2 Canada
???8.2 European Anti-snoring Treatment Market Sales Analysis – Product Type | Treatment Type | End User | Country ($ Million)
?????8.2.1 UK
?????8.2.2 Germany
?????8.2.3 Italy
?????8.2.4 Spain
?????8.2.5 France
?????8.2.6 Russia
?????8.2.7 Rest of Europe
???8.3 Asia-Pacific Anti-snoring Treatment Market Sales Analysis – Product Type | Treatment Type | End User | Country ($ Million)
?????8.3.1 China
?????8.3.2 Japan
?????8.3.3 South Korea
?????8.3.4 India
?????8.3.5 Australia & New Zealand
?????8.3.6 ASEAN Countries
?????8.3.7 Rest of Asia-Pacific
???8.4 Rest of the World Anti-snoring Treatment Market Sales Analysis – Product Type | Treatment Type | End User | Country ($ Million)
?????8.4.1 Latin America
?????8.4.2 Middle East and Africa
- Company Profiles
???9.1 AccuMed Corp.
????9.1.1 Quick Facts
????9.1.2 Company Overview
????9.1.3 Product Portfolio
????9.1.4 Business Strategies
???9.2 Advanced Brain Monitoring, Inc.
???9.3 Airway Management, Inc.
???9.4 Apnea Sciences Corporation
???9.5 Fisher & Paykel Healthcare Limited
???9.6 Glidewell Laboratories
???9.7 Great Lakes Dental Technologies
???9.8 Innovative Health Technologies
???9.9 Koninklijke Philips N.V.
???9.10 Meditas Ltd
???9.11 Oventus Medical Limited
???9.12 ProSomnus Sleep Technologies, Inc.
???9.13 PureSleep Company
???9.14 ResMed Inc.
???9.15 Rhinomed Limited
???9.16 Signifier Medical Technologies Limited
???9.17 Sleeping Well, LLC
???9.18 SML (Space Maintainers Laboratories)
???9.19 SomnoMed Limited
???9.20 Solutions 4 Snoring
???9.21 The Snore Free Company
???9.22 Theravent, Inc.
???9.23 TOMED GmbH
???9.24 VitalSleep LLC
???9.25 Whole You, Inc.
1. Global Anti-snoring Treatment Market Research and Analysis by Product Type, 2025–2035 ($ Million)
2. Global Mandibular Advancement Devices (MADs) Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Nasal Devices Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Positive Airway Pressure (PAP) Devices Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Chin Straps Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Position Control Devices Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Tongue Stabilizing Devices (TSDs) Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Anti-snoring Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million)
9. Global Anti-snoring Treatment Market Research and Analysis for Device-based Treatment by Region, 2025–2035 ($ Million)
10. Global Anti-snoring Treatment Market Research and Analysis for Surgical Treatment by Region, 2025–2035 ($ Million)
11. Global Anti-snoring Treatment Market Research and Analysis for Pharmacological Treatment by Region, 2025–2035 ($ Million)
12. Global Anti-snoring Treatment Market Research and Analysis for Lifestyle & Behavioral Therapy by Region, 2025–2035 ($ Million)
13. Global Anti-snoring Treatment Market Research and Analysis by End User, 2025–2035 ($ Million)
14. Global Anti-snoring Treatment Market Research and Analysis for Hospitals by Region, 2025–2035 ($ Million)
15. Global Anti-snoring Treatment Market Research and Analysis for Sleep Clinics & Diagnostic Centers by Region, 2025–2035 ($ Million)
16. Global Anti-snoring Treatment Market Research and Analysis for Homecare Settings by Region, 2025–2035 ($ Million)
17. Global Anti-snoring Treatment Market Research and Analysis for ENT Clinics by Region, 2025–2035 ($ Million)
18. Global Anti-snoring Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
19. North America Anti-snoring Treatment Market Research and Analysis by Country, 2025–2035 ($ Million)
20. North America Anti-snoring Treatment Market Research and Analysis by Product Type, 2025–2035 ($ Million)
21. North America Anti-snoring Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million)
22. Europe Anti-snoring Treatment Market Research and Analysis by Country, 2025–2035 ($ Million)
23. Europe Anti-snoring Treatment Market Research and Analysis by Product Type, 2025–2035 ($ Million)
24. Europe Anti-snoring Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million)
25. Asia-Pacific Anti-snoring Treatment Market Research and Analysis by Country, 2025–2035 ($ Million)
26. Asia-Pacific Anti-snoring Treatment Market Research and Analysis by Product Type, 2025–2035 ($ Million)
27. Asia-Pacific Anti-snoring Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million)
28. Rest of the World Anti-snoring Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
29. Rest of the World Anti-snoring Treatment Market Research and Analysis by Product Type, 2025–2035 ($ Million)
30. Rest of the World Anti-snoring Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million)
1. Global Anti-snoring Treatment Market Share by Product Type, 2025 vs 2035 (%)
2. Global Mandibular Advancement Devices (MADs) Market Share by Region, 2025 vs 2035 (%)
3. Global Nasal Devices Market Share by Region, 2025 vs 2035 (%)
4. Global Positive Airway Pressure (PAP) Devices Market Share by Region, 2025 vs 2035 (%)
5. Global Chin Straps Market Share by Region, 2025 vs 2035 (%)
6. Global Position Control Devices Market Share by Region, 2025 vs 2035 (%)
7. Global Tongue Stabilizing Devices (TSDs) Market Share by Region, 2025 vs 2035 (%)
8. Global Anti-snoring Treatment Market Share by Treatment Type, 2025 vs 2035 (%)
9. Global Anti-snoring Treatment Market Share for Device-based Treatment by Region, 2025 vs 2035 (%)
10. Global Anti-snoring Treatment Market Share for Surgical Treatment by Region, 2025 vs 2035 (%)
11. Global Anti-snoring Treatment Market Share for Pharmacological Treatment by Region, 2025 vs 2035 (%)
12. Global Anti-snoring Treatment Market Share for Lifestyle & Behavioral Therapy by Region, 2025 vs 2035 (%)
13. Global Anti-snoring Treatment Market Share by End User, 2025 vs 2035 (%)
14. Global Anti-snoring Treatment Market Share for Hospitals by Region, 2025 vs 2035 (%)
15. Global Anti-snoring Treatment Market Share for Sleep Clinics & Diagnostic Centers by Region, 2025 vs 2035 (%)
16. Global Anti-snoring Treatment Market Share for Homecare Settings by Region, 2025 vs 2035 (%)
17. Global Anti-snoring Treatment Market Share for ENT Clinics by Region, 2025 vs 2035 (%)
18. Global Anti-snoring Treatment Market Share by Region
19. US Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
20. Canada Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
21. UK Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
22. France Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
23. Germany Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
24. Italy Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
25. Spain Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
26. Russia Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
27. India Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
28. China Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
29. Japan Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
30. South Korea Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
31. Australia & New Zealand Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
32. ASEAN Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
33. Rest of Asia-Pacific Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
34. Latin America Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
35. Middle East & Africa Anti-snoring Treatment Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
